In Burkitt’s lymphoma (Daudi) and leukemia cells, loss of RB1 function appears to be reversible, and IFN-β signaling induces RB1 gene expression or restores RB1 function by reducing its phosphorylation (23–30). Here, RB1 is linked to leukemia.